Skip to main content
SpringerLink
Log in

Colorectal carcinomas

  • Chapter
PET in Clinical Oncology

  • 151 Accesses

Incidence

Colorectal cancer is the second most common cancer in the western world [7]. It is the third most common cancer, after prostata carcinoma and lung carcinoma for men and after breast carcinoma and lung carcinoma for women. In the United States colorectal cancer is the second leading cause of cancer-related death, after lung cancer [10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdel-Nabi HH, Dörr RJ (1992) Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR 103) in patients with colorectal carcinoma. Targeted Diagn Ther 6:73–88

    PubMed  CAS  Google Scholar 

  2. Abdel-Nabi HH, Dörr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB (1998) Stating of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760

    PubMed  CAS  Google Scholar 

  3. Barbaro B, Valentin V, Manfredi R (1995) Combined modality staging of high risk rectal cancer. Rays 20:165–181

    PubMed  CAS  Google Scholar 

  4. Bares R, Fass J, Hauptmann S, Braun J, Grehl O, Reinartz R, Büll U, Schumpelick V, Mittermayer C (1993) Quantitative analysis of anti-CEA antibody accumulation in human colorectal carcinomas. Nuklearmedizin 32:65–72

    PubMed  CAS  Google Scholar 

  5. Brzezinski W (1992) Monoclonal antibodies - why should surgeons be interested? Mater Med Pol 24:271–272

    PubMed  CAS  Google Scholar 

  6. Burger C, Buck A (1997) Requirements and implementation of a flexible kinetic modeling tool. J Nucl Med 38:1818–1823

    PubMed  CAS  Google Scholar 

  7. Cancer and the Immune System: The Vital Connection http://www.cancerresearch.org

  8. Cappel J, Blum U, Ungeheuer E (1983) Bedeutung der Vorsorgeuntersuchung für die Prognose des Dickdarmkarzinoms. Schweiz Med Wochenschr 113:550–552

    PubMed  CAS  Google Scholar 

  9. Cohen AM, Minsky BD, Schilsky RL (1997) Cancer of the Colon staging and prognostic features. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, 5th edition. Lippincott-Raven Publishers, Philadelphia, pp 1155–1156

    Google Scholar 

  10. Colorectal Cancer http://www.medicare.gov

  11. Colon Cancer, http:http://www.health-center.com

  12. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133:510–515

    Article  PubMed  CAS  Google Scholar 

  13. Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright KJ Jr„ Chapman WC, Pinson CW (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201

    CAS  Google Scholar 

  14. Delorme S (1995) Sonographische Diagnostik in der Onkologie III-4. In: Zeller J, zur Hausen H (eds) Onkologie: Grundlagen-Diagnostik-Therapie-Entwicklungen, 1st edition. ecomed, Landsberg/Lech, pp 1–11

    Google Scholar 

  15. Dimitrakopoulou A, Strauss LG, Clorius JH, Ostertag H, Schlag P, Heim M, Oberdorfer F, Helus F, Haberkorn U, van Kaick G (1993) Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 34:1075–1081

    PubMed  CAS  Google Scholar 

  16. Dimitrakopoulou A, Strauss LG, Knopp MV, Haberkorn U, Helus F, Maier-Borst W (1992) Evaluation of modulated fluorouracil chemotherapy with positron emission tomography in patients with metastatic colorectal cancer. In: Breit (ed) Advanced Radiation Therapy Tumor Response Monitoring and Treatment Planning. Springer, Berlin Heidelberg, pp 227–230

    Google Scholar 

  17. Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Hohenberger P, Irngartinger G, Oberdorfer F, Doll J, van Kaick G (1998) Intravenous and intra-arterial oxygen-l5-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 39:465–473

    PubMed  CAS  Google Scholar 

  18. Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Hohenberger P, Möhler M, Oberdorfer F, van Kaick G (1998) Fluorine-l8-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med 39:1197–1202

    PubMed  CAS  Google Scholar 

  19. Engenhart R, Kimmig BN, Strauss LG, Höver KH, Romahn J, Haberkorn U, van Kaick G, Wannenmacher M (1992) Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 168:203–212

    PubMed  CAS  Google Scholar 

  20. Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, Pratt B, Husband J, Flower M, Ott R (1996) Noninvasive monitoring of tumor metabolism using fluordeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14:700–708

    PubMed  CAS  Google Scholar 

  21. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willet WC (1999) Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340:169–176

    Article  PubMed  CAS  Google Scholar 

  22. Golfieri R, Giampalma E, Leo P, Colecchia A, Selleri S, Poggioli G, Gozzetti G, Trebbi F, Russo A et al. (1993) Comparison of magnetic resonance (0.5 T), computed tomography, and endorectal ultrasonography in the preoperative stating of neoplasms of the rectum-sigma. Correlation with surgical and anatomopathologic findings. Radiol Med Torino 85:773–783

    PubMed  CAS  Google Scholar 

  23. Grabbe E, Winkler R (1985) Local recurrence after sphincter-saving resection for rectal rectosigmoid cancer. Value of diagnostic methods. Radiology 155:305–310

    PubMed  CAS  Google Scholar 

  24. Gupta NC, Falk PM, Frank AL, Thorson AM, Frick MP, Bowman B (1993) Pre-operative staging of colorectal carcinoma using positron emission tomography. Nebr Med J 78:30–35

    PubMed  CAS  Google Scholar 

  25. Haberkorn U, Strauss LG, Dimitrakopoulou A, Engenhart R, Oberdorfer F’, Ostertag H, Romahn J, van Kaick G (1991) PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Meal 32:1485–1490

    CAS  Google Scholar 

  26. Heim ME (1995) Gastrointestinale Tumoren V-2.5. In: Zeller J, zur Hausen H (eds) Onkologie: Grundlagen-Diagnostik-Therapie-Entwicklungen, 1st edition. ecomed, Landsberg/Lerch, pp 1–23

    Google Scholar 

  27. Imdahl A, Bräutigam P, Hauenstein KH, Eggstein S, Waninger J, Farthrnann EH (1994) The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study. Zentralbl Chir 119:17–22

    PubMed  CAS  Google Scholar 

  28. Keogan MT, Lowe VJ, Baker ME, McDermott VG, Lyerly HK, Coleman RE (1997) Local recurrence of rectal cancer: evaluation with F-18 fluordeoxyglucose PET imaging. Abdom Imaging 22:327–332

    Article  Google Scholar 

  29. Kontaxakis G, Tzanakos GS, Strauss LG, Dimitrakopoulou-Strauss A, Mantaka P, van Kaick G (1997) Characteristics of the local convergence behavior of the iterative ML-EM image reconstruction algorithms for PET. J Nucl Med 38:202P (abstr)

    Google Scholar 

  30. Kummer D, Bertsch G, Breucha G, Domers B, Müller GE, Sommer (1997) Die Bedeutung der Krebsnachsorge beim Magen-, Dick-and Mastdarmoperierten. Med Welt 28:1920–1925

    Google Scholar 

  31. Lai DT, Fulham M, Stephen MS, Chu KM, Solomon M, Thompson JF, Sheldon DM, Storey DW (1996) The role of whole-body positron emission tomography with 18Ffluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703–707

    Article  PubMed  CAS  Google Scholar 

  32. Leitha T, Baur M, Steger D, Dudczak R (1990) Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations. Wien Klin Wochenschr 102:503–509

    PubMed  CAS  Google Scholar 

  33. Lynch HT, Smyrk TC (1998) Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 338:1537–1538

    Article  PubMed  CAS  Google Scholar 

  34. Mantaka P, Dimitrakopoulou-Strauss A, Gutzler F, Kontaxakis G, Schlag P, Oberdorfer F, van Kaick G, Strauss LG (1997) Evaluation of PET-FDG for the detection and differential diagnosis of liver lesions. J Nucl Med 38:137P (abstr)

    Google Scholar 

  35. Meyenberger C, Wildi S, Kulling D, Bertschinger P, Zala GF, Klotz HP, Krestin GP (1996) Tumor staging and follow-up care in rectosigmoid carcinoma: colonoscopic endosonography compared to CT, MRI and endorectal MRI. Schweiz Rundsch Med Prax 85:622–631

    CAS  Google Scholar 

  36. Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C (1998) A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inform 23:207–214

    Article  CAS  Google Scholar 

  37. Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP (1998) Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med 23:3–7

    Article  PubMed  CAS  Google Scholar 

  38. Möhler M, Dimitrakopoulou-Strauss A, Gutzler F, Räth U, Strauss LG, Stremmel W (1998) 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with liver metastases to the liver treated with 5-fluorouracil. Cancer 83:245–253

    Article  Google Scholar 

  39. Muxi Pradas MA, Pons-Pons F, Huguet-Planella M, Novell-Capilla F, Garcia-Romero RH, Trias-Fo Ich M (1996) Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma. Med Clin Barc 107:601–607

    PubMed  CAS  Google Scholar 

  40. Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Flesh-man JW, Read TE, Philpott GW, Kodner IJ (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620

    Article  PubMed  CAS  Google Scholar 

  41. Polk HC, Spratt JS (1971) Recurrent colorectal carcinoma: detection, treatment and other considerations. Surgery 69:9–13

    PubMed  Google Scholar 

  42. Potter JD (1999) Fiber and colorectal cancer. N Engl J Med 340:223–224 (editorial)

    Article  PubMed  CAS  Google Scholar 

  43. Sancar A (1994) Mechanisms of DNA excision repair. Science 266:1954–1956

    Article  PubMed  CAS  Google Scholar 

  44. Scharling ES, Wolfman NT, Bechtold RE (1996) Computed tomography evaluation of colorectal carcinoma. Semin Roentgenol 31:142–153

    Article  PubMed  CAS  Google Scholar 

  45. Smith FW, Heys SD, Evans NTS, Roeda D, Gvozdanovic D, Eremin O, Mallard JR (1992) Pattern of 2-deoxy-2–18F-fluoro-D-glucose accumulation in liver tumours: Primary, metastatic, and after chemotherapy. Nucl Med Comm 13:193–195

    Article  CAS  Google Scholar 

  46. Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23:1409–1415

    Article  PubMed  CAS  Google Scholar 

  47. Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, Marin-Grez M, Helus F, Oberdorfer F, Schmidlin P, van Kaick G (1989) Recurrence of colorectal tumors: PET evaluation. Radiology 170:329–332

    PubMed  CAS  Google Scholar 

  48. Thoeni RF, Rogalla P (1995) CT for evaluation of carcinomas in the colon and rectum. Semin Ultrasound CT MR 16:112–126

    Article  PubMed  CAS  Google Scholar 

  49. Thompson WM, Halvorsen RA, Foster WL, Roberts L, Gibbons R (1987) Computed tomography of the rectum. RadioGraphics 7:773–807

    PubMed  CAS  Google Scholar 

  50. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK (1996) Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 23:737–743

    Article  PubMed  CAS  Google Scholar 

  51. Vitola JV, Delbeke D, Meranze SG, Mazer MJ, Pinson CW (1996) Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 78:2216–2222

    Article  PubMed  CAS  Google Scholar 

  52. Yonekura Y, Benua RS, Brill AB, Som P, Yeh SD, Kemeny NE, Fowler JS, MacGregor RR, Stamm R, Christman DR, Wolf AP (1982) Increased accumulation of 2-deoxy-218F-fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 23:1133–1137

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Dimitrakopoulou-Strauss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bundeswehrzentralkrankenhaus Koblenz, Abteilung XV - Nuklearmedizin, Rübenacher Straße 170, Koblenz, 56072, Germany

    H. J. Wieler

  2. Division of Nuclear Medicine, Department of Radiology, DUMC 3949, Room 1419, Duke North Erwin Road, Durham, NC, 27710, USA

    R. Edward Coleman M.D. (Professor of Radiology, Vice-Chairman, Director) (Professor of Radiology, Vice-Chairman, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dimitrakopoulou-Strauss, A. (2000). Colorectal carcinomas. In: Wieler, H.J., Coleman, R.E. (eds) PET in Clinical Oncology. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57703-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57703-1_19

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63329-4

  • Online ISBN: 978-3-642-57703-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation